Shukra Pharmaceuticals P/B Ratio
Shukra Pharmaceuticals P/B ratio. Shukra Pharmaceuticals (SHUKRAPHAR) P/B ratio is 29.16 (High), book value per share ₹20.45 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Browse SHUKRAPHAR balance sheet details for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
SHUKRAPHAR P/B Ratio — Valuation Insights & Book Value Analysis
Shukra Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 29.16 (High). Read SHUKRAPHAR dividend history for the complete payout history and dividend yield track record.
- Stock appears overvalued with PB of 29.16, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 614.7% above historical average
- Trading at premium to sector average PB of -0.3
Shukra Pharmaceuticals P/B Ratio Historical Trend
SHUKRAPHAR annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see SHUKRAPHAR share price.
SHUKRAPHAR Historical P/B Ratio — Book Value Per Share & Year-End Price
Shukra Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 4.02 | ₹20.45 | ₹82.20 | ₹90 | High |
| 2025 | 4.14 | ₹14.32 | ₹59.25 | ₹63 | High |
SHUKRAPHAR vs Healthcare Peers — P/B Ratio Comparison
Shukra Pharmaceuticals P/B 29.16 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |